The technology, which led to a shift in strategy more than half of the time, could save $719 per symptomatic patient over 10 years.

The company reported revenue of $37.2 million in the first quarter, up 39% year over year, but said it has faced challenges ...

A special session at SCCT was dedicated to the history of the field, but also explored future directions and unanswered ...

What if the cure for a life-threatening heart condition wasn't a drug or surgery, but a supplement you could find on a store ...

Surgeons performed chest reconstruction to enable an oversized heart transplant in a toddler, and 25-year follow-up shows the ...

The use of the radial access site for PCI has surged in the US and offers better clinical outcomes than the femoral site, but ...

HeartFlow recently filed a Form S-1 with the SEC to confirm its intent to complete an initial public offering (IPO) and go ...

VS Achuthanandan's longevity was attributed to his disciplined lifestyle, including daily walks, yoga, and frugal eating ...

The document, which was obtained by TMZ, also revealed Michael had thromboembolic disease - blood clots causing obstruction of vessels or arteries - at the time of his passing. Wh ...

The Centers for Medicare & Medicaid Services (CMS) on July 15, 2025, issued the Hospital Outpatient Prospective Payment (OPPS) and Ambulatory ...

In yet another milestone, Indiana Hospital & Heart Institute, renowned for its advanced Structural Heart Disease Programme, has successfully performed two valve-in-valve TAVR procedures in Mangaluru, ...